The CD20+CXCR4+CD4+ B cells in MC16 of HIV-negative displayed elevated Bcl-6 expression compared to HIV+ cART-naïve (p < 0.0001) and HIV+ pre-NHL (cART-naïve) samples (p = 0.005). This evidence concerns the gene BCL6 and non-Hodgkin lymphoma.